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 ABSTRACT 
 
It was found that the distribution and metabolism of many biologically active compounds 
in the body whether drugs or natural products are correlated with their affinities toward 
serum albumin. Thus, the study on the interaction of such molecules with albumin is of 
imperative and fundamental importance. Extensive studies on different aspects of drug–
HSA interactions are still in progress because of the clinical significance of the processes.  
In this study the interaction of steroid hormones (progesterone and its parent compound 
cholesterol) with human serum albumin at physiological pH have been studied using UV-
VIS spectrophotometer, fluorescence spectrophotometer, and FT-IR spectroscopy.  
The results showed that UV absorption intensity spectra were increased with the increase 
of progesterone or cholesterol molar ratios in fixed amount of HSA. From UV spectra the 
binding constants were obtained and equals (6.354×102M-1)for progesterone and 
(0.2641×104M-1) for cholesterol. 
Beside that the results that have been obtained from analysis of fluorescence spectra 
indicated that progesterone and cholesterol have an ability to quench the intrinsic 
fluorescence of HSA through a static quenching procedure. The values of Stern-Volmer 
constant were determined to be (6.26×102 L mol-1) for progesterone- HSA complexes and 
(6.21×102 L mol-1)  for  cholesterol- HSA  complexes. Also the quenching  rate  constant  
 
iii 
values obtained were (6.20×1010 L mol-1s-1) for progesterone, and (6.21×1010 Lmol-1s-1) 
for cholesterol. 
The binding constants from fluorescence spectrum for progesterone- HSA complexes was 
found to be (6.56×102 M-1), and for cholesterol- HSA complexes was found to be (0.214 
× 104 M-1). It was obviously noted that the obtained values agrees well with the values 
obtained using UV-VIS spectrophotometer, and that cholesterol binding constant is larger 
than progesterone binding constant, this refer to the structure of the two compounds 
which is consistent with that have been reported.  
FT-IR spectroscopy with Fourier self-deconvolution and second derivative, as well as 
curve fitting procedures were used in the analysis of amide I, amide II, and amide III 
regions of  HSA to determine protein secondary structure and hormone binding 
mechanism. It was observed that the intensity of absorption bands decreased as 
progesterone or cholesterol molar ratios increased. Also all peak positions of the three 
amide regions were assigned at different progesterone or cholesterol ratios. 
In addition FT-IR spectra evidence showed that HSA secondary structure has been 
changed as progesterone or cholesterol molar ratios increased, which was observed in the 
reduction of α-helices absorption band relative to β-sheets absorption band. The variation 
in the intensity is related indirectly to the formation of H-bonding in the complex 
molecules, which accorded for the different intrinsic propensities of α-helix and β-sheets. 
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Chapter one 
Introduction. 
This thesis is an experimental investigations of the effects of the interaction of steroid 
hormones (progesterone and its parent compound; cholesterol) with HSA by means of UV-
VIS spectrophotometer, fluorescence spectrophotometer, and FT-IR spectroscopy. 
Hormones are the most familiar compound to the general public, because of the 
medications use and abuse of steroid hormones for diverse purposes, such as contraception 
and body building (Hardie, 1991).  
Hormones have many physiological effects on human body; the disorders of hormones 
may cause many abnormalities in it (Korkmaz et al., 2005; Andr´e et al., 2003). 
Progesterone, is one of the steroid hormones, and is synthesized from cholesterol (Hardie, 
1991), and is secreted naturally by the corpus luteum. Progesterone is a C-21 steroid 
hormone; its chemical structure is shown in Fig.(1.1) (Korkmaz et al., 2005). 
 
 
 
 
 
Figure 1.1: Chemical structure of progesterone. 
Cholesterol is an extremely important biological molecule being a major component of cell 
membrane as well as a precursor for the synthesis of a number of essential vitamins, 
steroid hormones and bile acids (Pani et al., 2003), its chemical structure is shown in 
Fig.(1.2). 
  3
 
 
 
 
 
 
 
Figure 1.2: Chemical structure of cholesterol. 
Human serum albumin (HSA) is the most abundant plasma carrier protein in  human body 
with a high affinity for a wide range of metabolites and drugs. The most important 
physiological role of HSA, is to transport such solutes in the blood stream and then deliver 
them to the target organs, as well as to maintain the pH and osmotic pressure of plasma 
(Maiti et al., 2008), its structure and function will be discussed briefly in chapter two. 
The molecular interactions between HSA and some compounds have been investigated 
successfully (Jürgens et al., 2002; Ouameur et al., 2004; Ha et al., 2006). It has recently 
been proved that serum albumin plays a decisive role in the transport and disposition of a 
variety of endogenous and exogenous compound such as free fatty acids, hormones, 
bilirubin, drugs… (Tang et al., 2006).  
The distribution and metabolism of many biologically active compounds in the body 
whether drugs or natural products are correlated with their affinities toward serum 
albumin. Thus, the study on the interaction of such molecules with albumin is of 
imperative and fundamental importance (Maiti et al., 2008). Extensive studies on different 
aspects of drug–HSA interactions are still in progress because of the clinical significance 
of the processes (Andr´e et al., 2003). 
In recent years, many investigations on drugs and natural products binding to protein were 
carried out. Progesterone and cholesterol, as a possible ligands, was not studied in detail on 
its binding reaction with HSA. It has been reported that progesterone and cholesterol binds 
to HSA (Morley, 1997; Peng et al., 2008). So far, none of the investigations determine in 
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details the progesterone-HSA, and cholesterol–HSA binding constants and the effects of 
progesterone or cholesterol complexation on the protein structure. 
In this thesis, the interaction of progesterone and its parent compound cholesterol with 
HSA will be investigated by means of FT-IR, UV-VIS, and fluorescence 
spectrophotometers.  
Infrared spectroscopy provides measurements of molecular vibrations due to the specific 
absorption of infrared radiation by chemical bonds. It is known that the form and 
frequency of the Amide I band, which is assigned to the C=O stretching vibration within 
the peptide bonds is very characteristic for the structure of the studied protein. From the 
band secondary structure, components peaks (α-helix, β-sheets) can be derived and the 
analysis of this single band allows elucidation of conformational changes with high 
sensitivity (Darwish et al., 2010).  
This work will be limited to the mid-range infrared, which covers the frequency range 
from 4000 to 400 cm-1. This wavenumber region includes bands that arise from three 
conformational sensitive vibrations within the peptide backbone (Amides I, II & III). 
Amide I is the most widely used and can provide information on secondary structure 
composition and structural stability. However, it has been reported that amide II and amide 
III bands have high information content and could be used for prediction of proteins 
secondary structure (Cui et al., 2008; Kang et al., 2004; Rondeau et al., 2007). 
Other spectroscopic techniques are usually used in studying drugs interaction with 
proteins, such as fluorescence and UV-VIS spectrophotometers which are commonly used 
because of their high sensitivity, rapidity and ease of implementation (Wybranowski et al., 
2008; Li et al., 2008; Li et al., 2006).  
This thesis includes five chapters; chapter two will discuss the theoretical aspects to guide 
readers to the important ideas of this study. Chapter three includes details of the 
experimental, procedures, and instruments used. In chapter four the results obtained are 
presented and discussed. Final chapter contains the conclusions and future work.  
 
  
 
  5
 
 
 
 
 
 
 
 
Chapter Two: 
Theoretical Background 
 
 
 
 
 
 
 
  6
 
 
 
Chapter two 
 Theoretical background. 
The emphasis on biophysics research has gradually changed over the years, in the early 
part of the 20th century, the research concentrated on issues related to medicine such as 
monitoring of heart and brain functions. 
In recent years more influence on biophysics research has been emphasized; this is due to 
ascending development in spectroscopic instrumentations, such as; (X-ray diffractions, 
electron microscope, computer assisted tomography scanning (CAT), magnetic resonance 
imaging (MIR), Fourier transform (FT-IR), Circular dichrosim (CD), UV-VIS, and 
fluorescence spectrophotometers. 
Spectrophotometers are powerful tools for studying biological samples such as proteins. 
This chapter will cover theoretical aspects on this research, the first two sections will 
include a short historical background on the development of FT-IR spectroscopy and 
Electromagnetic spectrum, next section will cover briefly molecular vibrations, the 
following three sections discuss the spectroscopic approaches used in this work; FT-IR, 
UV-VIS, and fluorescence spectrophotometers. Final section will include protein structure 
and the protein model that have been used in this work which is "Human Serum Albumin 
(HSA)".       
  
2.1 Fourier Transform Infrared (FT-IR) development. 
A wealth of information about structure and local microenvironment of biological 
materials; such as proteins, can be deduced from the spectral parameters: band position, 
band width and absorption; this standing due to the sensitivity and stability of 
spectrophotometers; which are valuable tools for the investigation of protein folding 
unfolding, and other protein structural changes during molecular interactions. IR 
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spectroscopy is one of the classical methods used for structure determination in biological 
systems, due to the high information content in an IR spectrum and its sensitivity to the 
chemical composition of molecules (Uversky, 2007).   
The discovery of IR spectroscopy goes back to the year 1800, when William Herschel 
discovered the IR portion of electromagnetic spectrum (Coblentz, 1951). However, 
Gruenwedel et al, 1984; mentioned that it was not until 1892 that Julius made the 
observation that the type of atoms present and their structural arrangement in the molecule 
determined the character of IR absorption. Since that time, spectacular advances have been 
made in the instrumentation from single beam to double beam dispersive spectrometers, 
and the development of Fourier transform IR spectrometer in 1960 that are operable over 
the entire IR range (Gruenwedel. et al., 1987).  
Quoting Jackson et al, 1995; the first use of infrared spectroscopy for determining the 
conformational structure of proteins and polypeptides was in 1950 by Elliot and Ambrose, 
who showed that an empirical correlation existed between the frequency of the so-called 
amide I and amide II absorptions of a protein and the predominant secondary structural 
motif within the protein as determined by X-ray diffraction studies (Jackson et al., 1995).  
As was reported by Lakowicz, 2006; a number of mathematical techniques, such as Fourier 
self deconvolution (FSD) and derivative, have been developed to study proteins, also a 
number of tools such as fluoruspectrophotometer became a widely used scientific tool in 
biophysics and material science after the pioneering works of Kasha, Vavilov, Perrin, 
Jabolonski, Weber, Stokes and Forster in 1951 (Lakowicz, 2006).  
 
2.2 Electromagnetic (EM) radiation. 
Spectroscopy is the study of the interaction of electromagnetic radiation with matter 
(Coleman, 1993). Electromagnetic radiations are transverse waves that consisting of both 
electric and magnetic fields which are oscillating in a perpendicular fashion to each other 
and to the direction of the propagation see Fig.(2.1) (Hollas, 2004).  
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Figure2.1: Representation of an electromagnetic wave. 
Electromagnetic radiation can be divided into different regions of energy that correspond 
to different spectroscopic techniques. The extent of the electromagnetic spectrum from 
low-energy Radio wave to high-energy γ-ray radiation is illustrated in Fig.(2.2) (Coleman, 
1993). The region from 4000 to 400 cm-1 is considered the mid-infrared region where 
vibrational and rotational bands are observed, and the region from 10 to 800 nm is the UV-
VIS region where the work of this thesis lies. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Electromagnetic spectrum. 
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In general, the spectrum gives information about the energy levels of the molecule, which 
helps to determine the structure of the molecule. In some types of spectroscopy there are 
only a few, well-separated energy levels. In these cases, only a very narrow range of 
wavelengths is absorbed by the molecule which is excited from it’s lowest energy state to 
some higher energy state, to give for each transition an absorption line. In many cases, 
each energy state has a number of energy sublevels , then a number of  closely spaced 
wavelengths are absorbed. The lines are so close together, therefore they can’t be resolved 
and the absorption appears as a band or a broad peak (Britlain et al., 1970). 
If molecules are exposed to EM radiation the radiation can be absorbed, transmitted, 
reflected, scattered or undergo photoluminescence*. According to quantum mechanical 
theory electromagnetic radiation and absorption can only occur at discrete energy levels. 
The discrete energy equals to hv where h is Planck's constant, v is the frequency. The 
absorbed EM radiation by a molecule can change its electronic state causing electron 
transitions, or changes in the internuclear distance of two or more atoms, or changes in the 
molecule rotation as it rotates around its center of mass. (OPUS Bruker manual, 2004) So 
the total energy of a molecule is due to electronic, vibrational, and rotational contributions 
as described in the equation below: 
Etotal= Eele+ Evib + Erot                                                                                                           (1)  
Where Etotal, Eele, Evib, and Erot stands for  total, electronic, vibrational, and rotational 
energy, respectively (Coleman, 1993; Hollas, 2004). 
2.3 Molecular Vibrations. 
IR spectroscopy is a technique based on the vibrations of the atoms of a molecule. An IR 
spectrum is commonly obtained by passing IR radiation through a sample and determining 
what fraction of the incident radiation is absorbed at a particular energy. The energy at 
which peak in absorption spectrum appears corresponds to a frequency of vibration of a 
part of a sample molecule. 
As the starting point for introducing the concept of molecular vibrations, it is instructive to 
consider molecules as an array of point masses that are connected with each other by mass-
less springs representing the intramolecular interactions between the atoms. The simplest 
case is given by two masses, m1 and m2, corresponding to a diatomic molecule m1–m2. 
Upon displacement of the spheres along the x-axis from the equilibrium position r0 by ∆x, 
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a restoring force (Fx) acts on the spheres, which according to Hooke’s law, is given by 
equation (1): 
                                   Fx = -K ∆x                                                                                         (2)              
Here K is the spring or force constant, which is a measure of the rigidity of the spring, that 
is, the strength of the bond. (Siebert et al., 2008) An illustration of this model is shown in 
Fig.(2.3). When this spring is stretched or compressed beyond the equilibrium distance of 
the bond, the potential energy of the system increases. When a bond vibrates, as for any 
harmonic oscillator, its energy of vibration is continuously and periodically changing from 
kinetic to potential energy. The total energy of the bond is proportional to the frequency of 
the vibration, as follows: 
                               Eosc α  vosc                                                                                              (3)  
This total energy for a harmonic oscillator is determined by the force constant of the spring 
(K), and the masses (ml and m2) of the two bonded atoms. The natural wavenumber (    ) of 
vibration of a bond is given by the equation, which is derived from Hooke's Law for 
vibrating springs.        
                                                                                                              (4)               
Where µ is the reduced mass of the system, is given by:    
                                                                                                                   (5)   
The force constant K varies from one bond to another (Bellamy, 1975). 
 
 
    
 
Figure 2.3: Diatomic model a)  relaxed b) stretched. 
* It’s a term used to designate a number of effects including phosphorescence and Raman 
scattering.  
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2.3.1 Normal modes of vibrations. 
In the Cartesian coordinate system, each atom can be displaced in the x-, y-, and z-
directions, corresponding to three degrees of freedom. Thus, a molecule of N nonlinear 
atoms has total 3N degrees of freedom, but not all of them correspond to vibrational 
degrees of freedom (Siebert et al., 2008). Three of which represent translational motion in 
mutually perpendicular directions (the x-, y- and z-axes) and three represent rotational 
motion about the x-, y- and z-axes. The remaining 3N- 6 degrees of freedom give the 
number of ways that the atoms in the molecule can vibrate, i.e. the number of vibrational 
modes (Chalmers et al., 2002). The degrees of freedom for polyatomic molecules, i.e linear 
or non linear (see Fig.(2.4)) are summarized in Table (2.1). 
 
 
 
Figure 2.4: Water and Carbon dioxide molecules. 
 
Table 2.1: Degrees of freedom for polyatomic molecules, (Stuart, 2004) 
 
The normal mode of vibration is defined as a molecular motion in which all the atoms 
move in phase and with the same frequency (Banwell, 1972). Two types of molecular 
vibrations correspond to the normal mode of the molecule: stretching and bending. 
Stretching is rhythmical movement along the bond axis and can be symmetric or 
antisymmetric. Bending vibrations arise from a change in bond angle between two atoms 
or movement of a group of atoms, relative to the remainder of the molecule.  
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For many vibrational modes, only a few atoms have large displacements and the rest of the 
molecule is almost stationary. The frequency of such modes is characteristic of the specific 
functional group in which the motion is centered and is minimally affected by the nature of 
the other atoms in the molecule. Thus the observation of spectral features in a certain 
region of the spectrum is often indicative of a specific chemical functional group in the 
molecule. For example, if a series of compounds which all contain an –OH group are 
examined, the infrared spectra universally show bands near 3500 and 1650 cm-1 
corresponding to the –OH stretching and bending modes, respectively. Even though most 
other atoms in the molecule also vibrate, their effect on the –OH constituent is relatively 
small (Mirabeela,1998). 
 
2.3.2 Quantum mechanical treatment of vibrations. 
I. The harmonic approximation. 
According to classical mechanics, a harmonic oscillator may vibrate with any amplitude, 
which means that it can possess any amount of energy, large or small. Quantum 
mechanics, however, shows that molecules can only exist in definite energy states. In the 
case of harmonic potentials, these states are equidistant, 
                                                                                                        (6) 
where ni is the vibrational quantum number, which can take only positive integer values 
including zero, h is Planck’s constant (Schrader, 1995). The potential energy, Viv, of a 
harmonic oscillator is shown by the dashed line in Fig.(2.5) as a function of the distance 
between the atoms, r (Griffiths et al., 2007). 
 
II.  Anharmonicity. 
The bonds in actual molecules, however, are not obeying Hooke's law exactly, the actual 
variation of the potential energy as a function of the displacement of the atoms from their 
equilibrium positions is shown as the solid line in Fig.(2.5). 
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From this curve it can be seen that equation (5) is only valid for low values of the 
vibrational quantum number, and is not valid when vi is large. In practice, Viv must be 
described using an anharmonic (Morse-type) potential function. This behavior is shown on 
Fig.(2.5) as the solid line, and the vibrational energy becomes:  
                                                                    (7) 
Where xi is the anharmonicity constant. xi is dimensionless and typically has values 
between 0.001 and 0.02 depending on the mode. If all vibrational modes were strictly 
harmonic, no transitions involving changes in ni by more than ±1 would be allowed. The 
effect of anharmonicity is to relax this selection rule, i.e. to allow bands caused by |∆ni| > 1 
to become allowed (Chalmers et al., 2002).  
 
 
 
 
 
 
 
 
Figure 2.5:  potential energy of a diatomic molecule as a function of the atomic 
displacement during vibration for a harmonic oscillator (dashed line) and an anharmonic 
oscillator (solid line) (Griffiths et al., 2007). 
 
2.3.3 Vibrational modes of polyatomic molecules. 
As discussed by Schermann, 2008; in a polyatomic molecule containing N atoms, 3N 
degrees of freedom describe the whole molecule (3 per atom). After removal of the centre 
of mass motion and rotation of the whole molecule, 3N-6 vibrational degrees of freedom 
must be considered. In a given normal mode of vibration Qi, all nuclei undergo harmonic 
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motion and move in phase with different amplitudes. All nuclei have the same frequency 
of oscillation. The potential energy is then given by:  
                                                                     (8) 
Ve is the energy minimum usually taken as the origin (Ve=0) and the λi are the force 
constants. In a first approximation, the vibrational motion of a polyatomic molecule can 
then be considered as the sum of 3N-6 harmonic motions and the vibrational energy is 
then: 
                                                                                                                                          (9) 
In the lowest energy state, n1=0, n2=0… and the vibrational energy is equal to the zero-
point energy 
                                                                                                 (10)                        
In general, normal modes of vibrations involve the movement of all atoms of a molecule 
but, in some cases, the movement is more or less localized on a single bond of the 
molecule as in a diatomic molecule, the potential energy of a polyatomic molecule is not a 
simple sum of harmonic energies but anharmonic terms must be considered: 
                                                 (11) 
The vibrational energy becomes: 
      )+…     (12) 
The existence of the anharmonicity terms xij introduces coupling between normal modes. 
The selection rules are no longer ∆ni =1 but overtones (∆ni =2) and intercombination bands 
with frequencies nini+njnj appear. This has several consequences. From the lowest 
vibrational energy state n1=n2=…=ni=0, the frequency of an absorbed photon is equal to 
one of the fundamental vibrational frequencies ni or one of its harmonics nivi. When the 
internal energy of a molecule increases due to vibrational excitation, either by absorption 
of photons or following collisions, the density of vibrational states (number of vibrational 
energy levels per frequency unit) increases extremely rapidly. The vibrational levels can no 
longer be considered as discrete but rather as forming a quasi-continuum. Nearly any 
photon energy can then be absorbed (Schermann, 2008).  
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2.4 FT-IR Spectroscopy. 
Since the development of the first spectrophotometers in the beginning of the 20th century 
a rapid technological development has taken place. The first generation spectrometers were 
all dispersive. Initially, the dispersive elements were prisms, and later, they changed over 
the gratings (OPUS Bruker manual, 2004). 
In the mid 1960s IR spectroscopy witnessed a revival due to the advent of spectrometers 
that utilized the Fourier transform. These second generation spectrometers, with an 
integrated Michelson interferometer, provided some significant advantages compared to 
dispersive spectrometers (OPUS Bruker manual, 2004). The most important advantage of 
FT-IR spectroscopy for biological studies is that spectra of almost any biological system 
can be obtained in a wide variety of environments (Li et al., 2007). 
2.4.1 Infrared (IR) spectroscopy. 
IR spectroscopy is certainly one of the most important analytical techniques available to 
today's scientists. One of the great advantages of IR spectroscopy is that virtually any 
sample in virtually any state may be studied; liquids, solutions, pastes, powders, films, 
fibers, gases and surface can all be examined with a judicious choice of sampling 
technique (Stuart, 2004).  
 
2.4.1.1 IR-region. 
Infrared radiation spans a section of the electromagnetic spectrum adjacent to the visible 
spectral region and extends from wavelength, roughly 0.78µm to about 1000µm. IR 
spectroscopists do not usually use the wavelength to plot their spectra but rather the inverse 
of the wavelength; the wavenumber. This quantity has the advantage of being proportional 
to vibrational frequency and the vibrational energy (Uversky, 2007). So the wavenumber 
range of IR radiation is from about 12800 to 10 cm−1. IR spectrum is conveniently divided 
into three regions due to their location relative to visible spectrum near-, mid-, and far-IR 
regions; the rough limits of each are shown in Fig.(2.6) (Serdyuk et al., 2007).  
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Figure 2.6 : Regions of IR spectrum. 
 
2.4.1.2 IR Spectrum presentation. 
In IR spectroscopy the horizontal coordinate of the spectrum runs from high wavenumbers 
to low wavenumbers according to a recommendation of the international union of pure and 
applied chemistry this is equivalent to running from small wavelength to large wavelength 
(Uversky, 2007). 
IR absorption is generally presented in the form of a spectrum showing wavelength or 
wavenumber versus transmittance or absorption intensity. The Transmittance (T), is the 
ratio of radiant power transmitted by the sample (I) to the radiant power incident on the 
sample (I0). Absorbance (A) is the logarithm to the base 10 of the reciprocal of the 
transmittance (T) as shown in equation (9), 
          (13)        
The transmittance spectra provide better contrast between intensities of strong and weak 
bands, because transmittance ranges from 0 to 100%; whereas absorbance ranges from 
infinity to zero (Settle, 1997).  
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2.4.1.3 Principle of IR absorption. 
As with other types of energy absorption, molecules are excited to a higher energy state 
when they absorb infrared radiation. The absorption of infrared radiation is, like other 
absorption processes; a quantized process. A molecule absorbs only selected frequencies 
(energies) of infrared radiation. The absorption of infrared radiation corresponds to energy 
changes on the order of 8 to 40 kJ/mole. Radiation in this energy range corresponds to the 
range encompassing the stretching and bending vibrational frequencies of the bonds in 
most covalent molecules. In the absorption process, those frequencies of infrared radiation 
that match the natural vibrational frequencies of the molecule in question are absorbed, and 
the energy absorbed serves to increase the amplitude of the vibrational motions of the 
bonds in the molecule. However, not all bonds in a molecule are capable of absorbing 
infrared energy, even if the frequency of the radiation exactly matches that of the bond 
motion. Only those bonds that have a dipole moment that changes as a function of time are 
capable of absorbing infrared radiation (Pavia et al., 2009).  
Almost all molecules absorb infrared light, and each type of molecule absorbs infrared 
light at certain frequencies only. This property provides a unique characteristic for each 
molecule. It provides a way to identify the molecule type (Qualitative analysis) and the 
amount or quantity of this molecule in the sample (Quantitative analysis). Since each type 
of molecule only absorbs at certain frequencies, it provides a unique absorption spectral 
pattern or fingerprint through the entire infrared light spectrum. In this way, the more 
molecules of the same type in the sample, the more infrared light is absorbed at those 
specific frequencies at which those molecules absorb infrared light. 
The height of the peaks are defined by the Beer-Lambert relationship (or Beer’s law). 
Beer’s law states that the concentration C is directly proportional to the absorbance A. 
That is: 
              A=abC                                                                                                                  (14) 
Where a is the absorptivity of the molecule and b is the path length or distance that the 
light travels through the sample (Workman, 1998).  
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2.4.2 Theory of FT-IR spectroscopy. 
FT-IR is an infrared spectroscopy which has the design of the optical pathway produces 
interference signals, which contain infrared spectral information called interferogram 
(Pavia et al., 2009).  
FT-IR Spectroscopy bases its functionality on the principle that almost all molecules 
absorb IR radiation (Banwell, 1972). The heart of an FT-IR spectrometer is an 
interferometer. Like the Michelson interferometer shown in Fig.(2.7) it has a fixed and a 
movable mirror. The latter generates a variable optical path difference between two beams 
and thus a detector signal that contains the spectral information. 
When the two beams recombine they interfere and there will be redistribution of energy 
interference depending on the optical path difference d. The instrument measures the light 
intensity relative to the position of the movable mirror and this is called an interferogram. 
It turns out that the interferogram is the fourier transform of the spectrum (Uversky, 2007). 
The interferogram is Fourier transformed with the help of computer to convert the space 
domain into the wave number domain (Vij, 2006). 
 
Figure 2.7: Optical arrangement of Michelson interferometer. M1 and M2 are a fixed and a 
moving mirror, respectively. B is the half-transparent surface of the beam splitter J, and K 
is a compensator plate. The beamsplitter and the compensator plate have the same 
thickness l and the same refractive index (Kauppinen et al., 2001).  
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The basic integral equation used in FT-IR spectroscopy can be obtained from the definition 
of Fourier integral theorem. The basic equation used in the case of the Michelson 
interferometer can be derived mathematically as reported by J. Kauppinen et al., 2001; as 
follows: 
Let us assume that the spectrum of the light source S0 is continuous and consists of a wide 
band of wavenumbers, so that the spectrum of the beams in both branches of the 
interferometer is E(ν), shown in Fig.(2.8). We shall assume that the source is still a point 
source. At a given optical path difference x, the interference signal from the infinitesimal 
spectral element between ν and ν + dν is, 
                                                (15) 
Consequently, the total signal from the whole spectral band is 
                                                                (16)    
F(x) is called an interference record. An interference record is the total interference signal 
of the whole spectral band, measured as the function of the optical path difference x. A 
typical interference record is shown in Fig.(2.9).  
If we subtract the constant term 
                                                                                  (17) 
from the interference record F(x), we obtain 
                                         (18)    
 I (x) is called an interferogram, and looks like as shown in Fig.(2.9). 
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Figure 2.8: A wide-band continuous spectrum E(v) and an infinitrsimal monochromatic 
section of the width dv (Kauppinen, 2001). 
 
 
 
 
 
 
Figure 2.9: An interference record F(x) (Kauppinen, 2001). 
If we define E(−ν) = E(ν), the computation is simplified, and we obtain 
              (19) 
Where F is the Fourier transform. Hence, I (x) and E(ν) form a Fourier transform pair, and 
they can be written as (Kauppinen, 2001):   
                    
(20) 
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2.4.3 The working principle of an FT-IR spectrometer. 
The basic components of an FT-IR spectrometer are shown schematically in Fig.(2.10.a) 
(Stuart, 2004). The working principle of an FT-IR spectrometer is as follows; a steady 
illumination from a broad-band IR source is modulated by a Michelson interferometer, i.e. 
a beam splitter that divides the collimated light along different paths to two mirrors. The 
light reflected from the fixed and moving mirrors is recombined at the beam splitter and is 
directed through the sample and into the IR detector. The path length difference between 
the light reflected from the fixed mirror and the light reflected from the moving mirror is 
measured very precisely. Next a computer stores the digitized interferogram and converts it 
via Fourier transformation to an IR spectrum. As illustrated in Fig.(2.10.b) (Serdyuk et al., 
2007).  
 
 
 
 
 
 
 
 
Figure 2.10: a) Basic components of FT-IR spectrometer. b) Simplified layout of an FT-IR 
spectrometer (Serdyuk et al., 2007). 
 
2.5 Ultraviolet-Visible (UV-VIS) spectrophotometer. 
When continuous radiation passes through a transparent material, a portion of the radiation 
may be absorbed. In the case of UV-VIS spectrophotometer, the transitions that result in 
the absorption of electromagnetic radiation in this region of the spectrum are transitions 
between electronic energy levels. As a molecule absorbs energy, an electron is promoted 
from an occupied orbital to an unoccupied orbital of greater potential energy.  
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For most molecules, the lowest-energy occupied molecular orbitals are the σ orbitals, 
which correspond to σ bonds. The π orbitals lie at somewhat higher energy levels, and 
orbitals that hold unshared pairs, the nonbonding (n) orbitals, lie at even higher energies. 
The unoccupied, or antibonding orbitals (π* and σ*), are the orbitals of highest energy. 
Fig.(2.11), shows a typical progression of electronic energy levels  (Pavia et al., 2009). 
 
 
 
 
 
Figure 2.11: Electronic energy levels. 
In all compounds, the electrons may undergo several possible transitions of different 
energies Fig.(2.12) illustrates these transitions (Pavia et al., 2009). 
 
 
 
 
 
 
Figure 2.12: Electronic energy transitions (Pavia et al., 2009). 
A spectrophotometer is an instrument that measures the intensity of a light beam as a 
function of wavelength. Spectrophotometers for the measurement of absorbance in the UV-
VIS range come in a variety of configurations. The most common routine laboratory 
instruments are single- or double-beam devices made up of a light source, monochromator, 
sample compartment, detector, data processor and display (Alan Cooper, 2004).  
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The absorption of UV light by proteins has been analyzed in detail and proposed as a 
structural probe from the very early days of molecular biology. The absorption of proteins 
in the UV arises mainly from electronic bands in the aromatic amino acid side-chains 
(tryptophan, tyrosine, phenylalanine) and, to a lesser extent, cysteine residues,  close to 280 
nm (Serdyuk et al., 2007; Alan Cooper, 2004).  
 
2.6 Fluorescence spectrophotometer. 
Fluorescence spectrophotometer is one of the most widely used spectroscopic techniques 
in the fields of biochemistry and molecular biophysics today (Cui et al., 2008; Royer, 
1995). Fluorescence is a particular case of luminescence, the other case is 
phosphorescence. Luminescence is an emission of ultraviolet, visible or infrared photons 
from an electronically excited species. (Valeur, 2002) Fluorescence is a phenomenon 
whereby a material absorbs light at one wavelength and then emits it at a longer 
wavelength (lower energy) (Jue, 2009).  
The processes that occur between the absorption and emission of light are usually 
illustrated by the Jablonski diagram, a typical Jablonski diagram is shown in Fig.(2.13) 
(Lakowicz, 2006). Quoting Lakowicz, 2006; The singlet ground, first, and second 
electronic states are depicted by S0, S1, and S2, respectively. At each of these electronic 
energy levels the fluorophores can exist in a number of vibrational energy levels, depicted 
by 0, 1, 2,...etc. The transitions between states are depicted as vertical lines to illustrate the 
instantaneous nature of light absorption. 
 
 
 
 
 
 
Figure 2.13 : One form of a Jablonski diagram (Lakowicz, 2006). 
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The fluorescence lifetime and quantum yield are the most important characteristics of a 
fluorophore. Quantum yield is the number of emitted photons relative to the number of 
absorbed photons. The lifetime is determine by the time available for the fluorophore to 
interact with or diffuse in its environment, and hence the information available from its 
emission (Lakowicz, 2006). 
It is clear that fluorescence is the result of an energy process that occurs in a molecule 
called fluorophore. The wavelength in manometer is determined by the spectral properties 
of the fluorophores. Fluorophores are divided into two main classes: (1) Intrinsic 
fluorophores are those that occur naturally, such as aromatic amino acids. (2) Extrinsic 
fluorophore are added to the sample to provide fluorescence when none exists, or to 
change the spectral properties of the sample (Lakowicz, 2006). 
Following light absorption, several processes usually occur. A fluorophore is usually 
excited to some higher vibrational level of either S1 or S2. An interesting consequence of 
emission to higher vibrational ground states is that the emission spectrum is typically a 
mirror image of the absorption spectrum of the S0 →S1 transition. This similarity occurs 
because electronic excitation does not greatly alter the nuclear geometry. Hence the 
spacing of the vibrational energy levels of the excited states is similar to that of the ground 
state. As a result, the vibrational structures seen in the absorption and the emission spectra 
are similar. 
Upon excitation into higher electronic and vibrational levels, the excess energy is quickly 
dissipated, leaving the fluorophore in the lowest vibrational level of S1. This relaxation 
occurs in about 10–12 s, and is presumably a result of a strong overlap among numerous 
states of nearly equal energy. Because of this rapid relaxation, emission spectra are usually 
independent of the excitation wavelength. 
The intensity of fluorescence can be decreased by a wide variety of processes. Such 
decreases in intensity are called quenching.  Quenching can occur by different 
mechanisms: Collisional quenching occurs when the excited-state fluorophore is 
deactivated upon contact with some other molecule in solution, which is called the 
quencher, and static quenching resulting from the formation of a ground state complex 
between the fluorophore and the quencher.                                                        
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For collisional quenching the decrease in intensity is described by the well-known Stern-
Volmer equation (Lakowicz, 2006): 
                                                                      (21)  
In this expression F and F0 are the fluorescence intensities with and without quencher, Ksv 
is the Stern-Volmer quenching constant, Kq is the bimolecular quenching constant, τ0 is the 
unquenched lifetime, and (L) is the quencher concentration. The Stern-Volmer quenching 
constant Ksv indicates the sensitivity of the fluorophore to a quencher.  
In proteins, Tryptophan, Phenylalanine, and Tyrosine; are the amino-acid residues mostly 
responsible for the absorbing and the emitting of energy. Fig.(2.14) shows the molecular 
schematics of the three residues. Tryptophan is known to be the most efficient intrinsic 
amino acid emitter residue (Jue, 2009). Due to a very low quantum yield of Phenylalanine, 
and the fluorescence of Tyrosine is almost completely quenched if that Tyrosine is ionized, 
near an amino group, a carboxyl group, or a Tryptophan (Zhang et al., 2008). 
 
 
 
 
 
Figure 2.14: Structure of the intrinsic fluorophores amongst amino acids. 
 
2.7 Proteins. 
Proteins are one of the important molecules of our life and the major target of many types 
of medication in the body (Zhang et al., 2008). Proteins are a particular type of biological 
molecules that can be found in every single living being on Earth. Proteins are polymers 
made up of specific sequences of amino acids linked together by covalent peptide (amide) 
bonds. Amino acids are chosen from a basic set of 20 building blocks differing in their 
side-chain. Amino acids have the general formula H2NCHRCOOH, where R is an organic 
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substituent (Fig.(2.15)). The number of amino acids units contained in the protein, the 
identity, and sequential order of the amino acids are used to distinguish proteins from one 
another (Cooper, 2004). 
 
 
 
 
 
 
Figure 2.15: General structure of amino acids. 
2.7.1 Protein structure. 
Protein chemical structure and molecular conformation are commonly described in terms 
of four levels of structure: Primary, Secondary, Tertiary, and Quaternary structure. Primary 
structure is the sequence of amino acids in the polypeptide chain which is unique to each 
protein (Cooper, 2004).  
The secondary structures imply the hierarchy by providing repeating sets of interactions 
between functional groups along the polypeptide backbone chain that creates, in turn, 
irregularly shaped surfaces of projecting amino acid side chains. The secondary structures 
in proteins arise from repeating patterns of similar peptide dihedral angles, for successive 
residues. 
Most protein structures are built up from combinations of α-helices and β-sheets, which 
form stable hydrophobic core, the remaining portions of protein structures are made up of 
well-ordered but nonrepetitive conformations referred to as coils. 
The C==O bond is parallel to the helical axis and the linear hydrogen bond formed 
between the C==O and N—H in the α-helix is the most stable geometrical arrangement. 
Fig.(2.16). 
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The polypeptide chains that form the β-structure are called β-strands. The β-strands are 
aligned adjacent to each other such that hydrogen bonds can form between N—H groups of 
one β-strand and C==O groups of an adjacent strand and vice versa alternatively to the left 
and to the right. Therefore the basic unit of β-sheet is not the individual β-strand but the β-
strand pair, which form hydrogen bonds between them. The β-structure that forms from 
several such β-strands is pleated, termed β-pleated sheet (β-sheet), with Cα atoms 
successively sticking slightly above and below the plane of the β-sheet. The β-strands in 
the β-sheet interact in two ways, i.e. parallel in which all amino acids in the aligned β-
strands run in the same direction, or antiparallel in which the amino acids in successive 
strands run in opposite directions (Tsai, 2007). 
Hydrogen bond networks that hold β-strands are different in parallel and antiparallel 
sheets. The parallel β-sheets have evenly spaced hydrogen bonds that angle across between 
the β-strands, whereas antiparallel β-sheets have parallel narrowly spaced hydrogen bonds 
that alternate with widely-spaced pairs. Fig.(2.17) (Tsai, 2007). 
 
 
 
 
 
 
 
 
 
Figure 2.16: The α-helix. The main chain carboxyl group of amino acid j is hydrogen 
bonded to the NH group of amino acid j+4 (Serdyuk et al., 2007). 
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Figure 2.17: Parallel (top) and antiparallel (bottom) β-sheets (Serdyuk et al., 2007). 
 
Tertiary structure describes the way in which the elements of protein  secondary structure 
are arranged in space and Quaternary structure describes how several polypeptide chains 
come together to form a single functional protein (Cooper, 2004). 
 
2.7.2 Human Serum Albumin (HSA). 
HSA is the most abundant protein in human plasma, which is synthesized in the liver 
(Fengling et al., 2006), and is able to bind and thereby transport, various compounds such 
as fatty acids, hormones, bilirubin, tryptophan, steroids, metal ions, therapeutic agents and 
a large number of drugs. HSA serves as the major soluble protein constituent of the 
circularity system, it contributes to colloid osmotic blood pressure, it can bind and carry 
drugs which are mainly poorly soluble in water (Peters, 1985). HSA accounts for 
approximately 60% of the total plasma protein corresponding to a concentration of 
40mg/ml in the blood (~0.6mM) (Tang et al., 2006).      
The three dimensional structure of HSA was determined through x-ray crystallographic 
measurements (He et al., 1992). This globular protein consists of a single polypeptide 
chain of 585 amino acids (Purcell et al., 2000), which have a molecular weight of 66 kDa 
(Bian et al., 2004).  
  29
This protein composed of three structurally similar domains (labeled as I, II, III). Each 
containing two sub domains ( A & B) having six and four α-helices, respectively (Curry et 
al., 1999), and stabilized by 17 disulphide bridges, that assemble to form a heart shaped 
molecule, see Fig.(2.18) (He et al., 1992; Bian et al., 2004). 
 
 
 
 
 
 
 
 
Figure 2.18: Chemical structure of human serum albumin (Abou-Zied, 2009). 
It has been shown that distribution, free concentration, and the metabolism of various 
drugs can be significantly altered as a result of their binding to HSA (Artali et al., 2004; 
Kang et al., 2004). The binding properties of albumin depend on the three dimensional 
structure of the binding sites, which are distributed all over the molecule. Strong binding 
can decrease the concentrations of free drugs in plasma, whereas weak binding can lead to 
a short lifetime or poor distribution or both.  Its remarkable capacity to bind a variety of 
drugs results in its prevailing role in drug pharmacokinetics and pharmacodynamics (P.B. 
Kandagal, et al., 2007).  
Multiple drug binding sites have been reported for HSA by several researchers 
(Bhattacharya, et al., 2000; Simard et al., 2006; Ulrich et al., 2006). The principal regions 
of ligand binding sites of HSA are located in hydrophobic cavities in sub domains IIA and 
IIIA, which are corresponding to site I and site II, respectively. Site I is dominated by  
strong hydrophobic interaction with most neutral, bulky, heterocyclic compounds, while 
site II mainly by dipole–dipole, van der Waals, and/or hydrogen-bonding interactions with 
many aromatic carboxylic acids. HSA contained a single tryptophan residue (Trp 214) in 
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domain IIA and its intrinsic fluorescence is sensitive to the ligands bounded nearby 
(Krishnakumar, et al., 2002; Il'ichev, et al., 2002). Therefore, it is often used as a probe to 
investigate the binding properties of drugs with HSA.  
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Chapter Three 
Experimental part. 
This chapter consists of three sections; section one contains information about samples, 
and film preparation. The next section includes a descriptions of the spectrometers used in 
this work, which are Bruker IFS 66/S FT-IR spectrophotometer, UV-VIS 
spectrophotometer (NanoDrop ND-1000), and Fluorospectrometer (NanoDrop
 
3300). The 
final section presents the experimental procedure in full details. 
 
3.1 Samples and materials.  
HSA (fatty acid free), progesterone, and cholesterol in powder form were purchased from 
Sigma Aldrich chemical company and used without further purifications.  
The data were collected using samples in the form of thin films for FT-IR measurements 
and liquid form for UV-VIS and fluorescence measurements. 
Preparations of the thin film samples required several stock solutions as described below: 
 
3.1.1 Preparation of HSA stock solution. 
HSA was dissolved in phosphate buffer saline, at physiological pH 7.4, to a concentration 
of (80mg/ml),  to get a final concentration of (40 mg/ml) in the final hormone- HSA 
solution. 
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3.1.2 Preparation of progesterone stock solution. 
Progesterone with molecular weight of (314.47 g/mol) was dissolved in phosphate buffer 
saline (0.7622 mg/ml), the solution was placed in ultrasonic water path (SIBATA AU-3T) 
for six hours to ensure that all the amount of progesterone was completely dissolved.  
 
3.1.3 Preparation of cholesterol stock solution.   
Cholesterol with molecular weight (386.66g/mol), was dissolve in phosphate buffer saline 
(0.9373 mg/ml), the solution was placed in ultrasonic water path (SIBATA AU-3T) for six 
hours to ensure that all the amount of cholesterol was completely dissolved.  
 
3.1.4 HSA-Progesterone solutions. 
The final concentrations of HSA-hormone solutions were prepared by mixing equal 
volume of HSA and hormone. HSA concentration in all samples kept at 40mg/ml. 
However, the concentration of hormone in the final protein hormone solutions was reduced 
such that the molecular ratios (HSA:hormone) are 10:18, 10:14, 10:10, 10:6, and 10:2.  
 
3.1.4 HSA-Cholesterol solutions. 
The final concentrations of HSA-cholesterol solutions were prepared by mixing equal 
volume of HSA and cholesterol. HSA concentration in all samples kept at 40mg/ml. 
However, the concentration of colesterol in the final protein cholesterol solutions was 
reduced such that the molecular ratios (HSA:cholesterol) are 10:18, 10:14, 10:10, 10:6, and 
10:2. 
3.1.5 Thin film preparations. 
 
Silicon windows (NICODOM Ltd) were used as spectroscopic cell windows. The optical 
transmission is high with little or no distortion of the transmitted signal. The 100% line of 
a NICODOM silicon window shows that the silicon bands in the mid- IR  region do not 
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exhibit total absorption and can be easily subtracted. 50µl of each sample of HSA-
progesterone was spread on a silicon widow and an incubator was used to evaporate the 
solvent, to obtain a transparent thin film on the silicon window. All solutions were 
prepared at the same time at room tempreture. 
The same procedure was followed for  HSA-cholesterol films preparation. 
 
3.2 Instruments. 
 
Many instruments can be used in studing the interaction of HSA with druges. In this work 
the following instruments have been used in taking the measurements. 
 
3.2.1 FT-IR Spectrometer. 
 
The FT-IR measurements were obtained on a Bruker IFS 66/S spectrophotometer equipped 
with a liquid nitrogen-cooled MCT detector and a KBr beam splitter. The spectrometer was 
continuously purged with dry air during the measurements. 
 
3.2.2 UV-VIS spectrophotometer (NanoDrop ND-1000). 
 
The absorption spectra were obtained by the use of a NanoDrop ND-1000 
spectrophotometer. It is used to measure the absorbtion spectrum of the samples in the 
range between 220-750nm, with high accuracy and reproducibility. 
 
3.2.3 Fluorospectrometer (NanoDrop
 
3300). 
 
The fluorescence measurements were performed by a NanoDrop ND-3300 
Fluorospectrophotometer at 25 oC. The excitation source comes from one of three solid-
state light emitting diodes (LED’s). The excitation source options include: UV LED with 
maximum excitation 365 nm, Blue LED with excitation 470 nm, and white LED from 500 
to 650nm excitation. A 2048-element CCD array detector covering 400–750 nm, is 
connected by an optical fiber to the optical measurement surface. The excitation is done at 
the wavelength of 360 nm and the maximum emission wavelength is at 439 nm.  Other 
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equipment such as Digital balance, pH meter, Vortex, Plate stir ... and Micropipettes were 
used (NanoDrop 3300  Fluorospectrometer  V2.7 User’s Manual,  2008). 
 
3.3 Experimental procedures. 
 
3.3.1 UV-VIS Spectrophotometer experimental procedures. 
 
Procedure of UV-VIS spectrophotometer was followed as described in NanoDrop 1000 
Spectrophotometer  V3.7, 2008, User’s Manual (NanoDrop 1000 Spectrophotometer  
V3.7, User’s Manual, 2008). Which is as follows:  
 
Operation  
A 1 µl sample of progesterone or cholesterol is pipetted into the end of a fiber optic cable 
(the receiving fiber). A second fiber optic cable (the source fiber) is then brought into 
contact with the liquid sample causing the liquid to bridge the gap between the fiber optic 
ends. The gap is controlled to both 1mm and 0.2 mm paths. A pulsed xenon flash lamp 
provides the light source and a spectrophotometer utilizing a linear CCD array is used to 
analyze the light after passing through the sample. The instrument is controlled by PC 
based software, and the data is logged in an archive file on the PC. 
 
Before taking the absorbance of samples the NanoDrop 1000 Spectrophotometer is 
“blanked”. When the NanoDrop 1000 Spectrophotometer is “blanked”, a spectrum is taken 
of a reference material (blank) and stored in memory as an array of light intensities by 
wavelength. When a measurement of a sample is taken, the intensity of light that has 
transmitted through the sample is recorded. The sample intensities along with the blank 
intensities are used to calculate the sample absorbance according to the following equation:  
Absorbance = -log (Intensity
sample
/Intensity
blank
)  
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Thus, the measured light intensity of both the sample and of the blank are required to 
calculate the absorbance at a given wavelength, and Beer-Lambert equation is used to 
correlate the calculated absorbance with concentration. 
Basic Use: The main steps for using the sample retention system are listed below: 
1. With the sampling arm open, pipette the sample onto the lower                       
measurement pedestal see photo one of Fig.(3.1). 
 
2. Close the sampling arm aninitiate a spectral measurement using the operating    
software on the PC. The sample column is  automatically drawn between the upper  
      and lower measurement pedestals and the  spectral measurement made see photo                       
two of Fig.(3.1). 
 
3. When the measurement is complete, open the sampling arm and wipe the   sample 
from both the upper and lower pedestals using a soft laboratory wipe.  Simple 
wiping prevents sample carryover  in successive measurements for samples  
varying by more than 1000 fold in concentration see photo  three of Fig.(3.1). 
 
 
 
 
 
 
 
Figure 3.1: Main steps for using the sample UV-VIS Spectrophotometer (NanoDrop1000). 
 
3.3.2 Fluorospectrophotometer experimental procedures. 
 
Procedure of Fluorospectrophotometer was followed as described in NanoDrop 3300  
Fluorospectrometer  V2.7, 2008  User’s Manual, (NanoDrop 3300  Fluorospectrometer  
V2.7 User’s Manual,  2008), which is as follows: 
Before taking the measurements of samples the NanoDrop 3300 Fluorospectrometer was 
“blanked”. 
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Operation 
  
A 1-2 µl sample of progesterone or cholesterol is pipetted onto the end of the lower 
measurement pedestal (the receiving fiber). A non-reflective “bushing” attached to the arm 
is then brought into contact with the liquid sample causing the liquid to bridge the gap 
between it and the receiving fiber. The gap, or pathlength, is controlled to 1mm. Following 
excitation with one of the three LEDs, emitted light from the sample passing through the 
receiving fiber is captured by the spectrophotometer. The NanoDrop 3300 is controlled by 
software run from a PC. All data is logged and archived in a folder at a user defined 
location. 
Basic Use: The main steps for making a measurement are listed below: 
1. With the sampling arm open, pipette the sample into the lower measurement 
pedestal see photo one of Fig.(3.2).  
 
2. Close the sampling arm and initiate a measurement using the operating software on 
the PC. The sample column is automatically drawn between the upper bushing and 
the lower measurement pedestal and the measurement is made see photo two of 
Fig.(3.2) . 
 
3. When the measurement is complete, open the sampling arm and wipe the sample 
from both the upper bushing and the lower pedestal using low lint laboratory wipe 
see photo three of Fig.(3.2).  
 
 
Figure 3.2: Main steps for using the sample Fluorospectrophotometer (NanoDrop
 
3300). 
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3.3.3 FT-IR Spectrometer  experimental procedures. 
 
The absorption spectra were obtained in the wave number range of 400–4000 cm-1. A 
spectrum was taken as an average of 60 scans to increase the signal to noise ratio, and the 
spectral resolution was at 4 cm-1. The aperture used in this study was 8 mm, since we 
found that this aperture gives best signal to noise ratio. Baseline correction, normalization 
and peak areas calculations were performed for all the spectra by OPUS software. The 
peak positions were determined using the second derivative of the spectra.  
The infrared spectra of HSA, progesterone–HSA complexes, and cholesterol-HSA 
complexes, were obtained in the region of 1000–1800 cm−1. The FT-IR spectrum of free 
HSA was acquired by subtracting the absorption spectrum of the buffer solution from the 
spectrum of the protein solution. For the net interaction effect, the difference spectra 
{(protein and progesterone/ cholesterol solution) – (protein solution)} were generated 
using the featureless region of the protein solution 1800-2200 cm–1 as an internal standard 
(Surewicz, et al, 1993). 
 
3.3.4 FT-IR data processing. 
The analysis of IR spectra in terms of protein structure is not straightforward and presents 
serious conceptual and practical problems, despite the well-recognized conformational 
sensitivity of the IR-active bonds. Bands in amide I, amide II and amide III regions are 
broad, not resolved into individual components corresponding to different secondary 
structure elements. 
Resolution enhancement or band-narrowing methods are applied to resolve broad 
overlapped bands into individual bands. FT-IR spectroscopy presents several advantages 
over conventional dispersive techniques for this type of analysis through the application of 
second derivative, peak picking, spectral subtraction, baseline correction, smoothing, 
integration, curve fitting, and Fourier self-deconvolution. 
In the present study several data processing tasks were used, such as: 
 
  39
3.3.4.1 Baseline correction. 
The baseline correction method applied here includes two steps. The first step is to 
recognize the baseline; this is done by selecting a point from spectral points on the 
spectrum. Then adding or subtracting a intensity value from the point or points to correct 
the baseline offset. Baseline correction task is used to bring the minimum point to zero. 
This is done automatically using Optic User Software (OPUS) and successfully removes 
most baseline offsets (Griffiths et al., 2007; OPUS Bruker manual , 2004). 
3.3.4.2 Peak picking. 
Automated peak picking involves two steps: (1) the recognition of peaks, and (2) the 
determination of the wavenumber values of maximum or minimum absorbance. A 
threshold absorbance value is usually set so that weak bands are not measured (Griffiths et 
al., 2007). 
3.3.4.3 Second derivative. 
Increased separation of the overlapping bands can be achieved by calculating the second 
derivative rate of change of slope of the absorption spectrum, second-derivative procedure 
have been successfully applied in the qualitative study of a large number of proteins (Haris 
et al., 1999). 
3.3.4.4 Fourier self-deconvolution. 
The Fourier deconvolution procedure, sometimes referred to as ‘resolution enhancement’ 
is the most widely used band narrowing technique in infrared spectroscopy of biological 
materials (Jackson et al., 1991). It involves narrowing the widths of infrared bands, 
allowing increased separation of the overlapping components present within the broad 
band envelope (Kauppinen, et al., 1981). 
Both second-derivative and deconvolution procedures have been successfully applied in 
the qualitative study of a large number of protein. (Workman, 1998; Kauppinnen et al, 
1981). In addition to providing valuable information about their secondary structure, the 
method has been shown to be useful for detecting conformational changes arising as a 
result of ligand binding, pH, temperature, organic solvents, detergents, ... etc. In many 
cases results obtained using this approach has been later supported by studies using other  
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techniques such as X-ray diffraction and NMR. However, both derivative and 
deconvolution techniques should be applied with care since they amplify the noise 
significantly (Haris et al., 1999). 
 
3.3.4.5 Spectral subtraction. 
Difference spectroscopy is another approach that is very useful for investigating subtle 
differences in protein structure. The principle of difference spectroscopy involves the 
subtraction of a protein absorbance spectrum in state A from that of the protein in state B. 
The resultant difference spectrum only shows peaks that are associated with those groups 
involved in the conformational change (Goormaghtigh, et al., 2006; Haris et al., 1999). 
The accuracy of this subtraction method is tested using several control samples with the 
same protein or drug concentrations, which resulted into a flat base line formation. 
 
3.3.4.6 Curve fitting. 
The Curve Fit command allows calculating single components in a system of overlapping 
bands. A model consisting of an estimated number of bands and a baseline should be 
generated before the fitting calculation is started. The model can be set up interactively on 
the display and is optimized during the calculation (OPUS Bruker manual, 2004). 
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Chapter Four 
 Results and discussion.  
This chapter includes the main results, analysis and discussions of our data. In the first 
section, UV-VIS spectrophotometer results are discussed and analyzed. The next section 
deals with fluorescence spectrophotometer results. In the final section, FT-IR graphs and 
data analysis are given. 
 
4.1 UV-VIS spectrophotometer. 
Many researchers have reported the effectiveness use of UV-VIS spectroscopy to 
investigate the interaction of drugs with HSA (Dukor, et al., 2001; Chirgadze. et al., 1975; 
Bi, et al., 2005). The absorption spectra of different ratios of  progesterone or cholesterol 
with fixed amount of HSA are displayed in Fig.(4.1) and Fig.(4.2), respectively. The 
excitation has been done on 210 nm and the absorption is recorded at 278 nm. The figures 
show that the UV-VIS intensity of HSA increases with the increasing of progesterone or 
cholesterol percentages, and that the absorption peaks of these solutions showed moderate 
shifts indicating that with the addition of progesterone or cholesterol, the peptide strands of 
HSA molecules extended more and the hydrophobicity of progesterone and cholesterol 
was decreased (Peng et al., 2008). The results indicated that an interaction occurred 
between progesterone or cholesterol with HSA. Obviously, it was seen from the spectrum 
that pure hormone and its parent compound cholesterol have little or no UV absorption. 
This results support that the peaks are due to the interaction between progesterone or 
cholesterol with HSA. Repeated measurements were done for all the samples showing 
consistent results and no significant differences were observed. 
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Figure 4.1: UV-Absorbance spectra of HSA with different molar ratios of progesterone 
(a=0:10, b=2:10, c=6:10, d=10:10, e=14:10, f=18:10). 
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Figure 4.2: UV-Absorbance spectra of HSA with different molar ratios of cholesterol 
(a=0:10, b=2:10, c=6:10, d=10:10, e=14:10, f=18:10). 
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4.1.1 Binding constants of progesterone or cholesterol and HSA complexes using  
      UV-VIS Spectrophotometer. 
 
The progesterone or cholesterol- HSA complexes binding constants were determined using 
UV-VIS spectrophotometer results according to published method (Stephanos, et al.,1996; 
Klotz, et al., 1971; Ouameur et al., 2004), by assuming that there is only one type of 
interaction between progesterone or cholesterol and HSA in aqueous solution, which leads  
to establish Equations. (1) and (2) as follows: 
 
HSA + Progesterone ↔ Progesterone: HSA                                                                       (1) 
HSA + Cholesterol ↔ Cholesterol: HSA 
K = [Progesterone: HSA]/ [Progesterone][HSA]                                                                (2) 
K = [Cholesterol: HSA]/ [Cholesterol][HSA] 
 
The absorption data were treated using linear double reciprocal plots based on the 
following equation (Lakowicz, 2006):              
                                                                                                                                          
                                                                                                                                             (3) 
 
where A0 corresponds to the initial absorption of protein at 280 nm in the absence of 
ligand, A∞ is the final absorption of the ligated protein, and A is the recorded absorption at 
different progesterone or cholesterol concentrations (L). The double reciprocal plot of 1/(A 
- A0) vs. 1/L is linear (Fig.(4.3) and (4.4)) and the binding constant (K) can be estimated 
from the ratio of the intercept to the slope to be (6.354×102M-1) and (0.2641×104M-1)for 
progesterone- HSA and cholesterol- HSA complexes, respectively. The values obtained is 
indicative of a weak progesterone or cholesterol protein interaction with respect to the 
other drug-HSA complexes with binding constants in the range of 105 and 106 M-1 (Kragh-
Hanse, 1981). The reason for the low stability of the progesterone or cholesterol-HSA 
complexes can be attributed to the presence of mainly hydrogen bonding interaction 
between protein donor atoms and the progesterone or cholesterol polar groups or an 
indirect hormone- protein interaction through water molecules. Similar weak interactions 
were observed in cis- Pt(NH3)2–HSA and taxol–HSA complexes (Purcell et al., 2000; 
Neault, et al., 1998). 
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Figure 4.3: The plot of 1/(A-Ao) vs 1/L for HSA with different concentrations of            
progesterone. 
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Figure 4.4: The plot of 1/(A-Ao) vs 1/L for HSA with different concentrations of 
cholesterol. 
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4.2 Fluorescence spectrophotometer. 
 
Fluorescence spectrophotometer is one of the most widely used spectroscopic techniques 
in the fields of biochemistry and molecular biophysics today (Royer, 1995). The auto 
fluorescence of HSA is attained mainly from the single tryptophan, tyrosine and 
phenylalanine residues. Actually, the intrinsic fluorescence of HSA is almost contributed 
by tryptophan alone, because phenylalanine has a very low quantum yield and the 
fluorescence of tyrosine is almost totally quenched if it is ionized or near an amino group, 
a carboxyl group or a tryptophan (Sulkowska, 2002). 
 
In this work for both HSA-progesterone or cholesterol complexes excitation wavelength at 
360nm was used, and the observed wavelength emission was at 439nm. The fluorescence 
sensor is based on intramolecular charge transfer (ICT), which is highly sensitive to the 
polarity of microenvironment. Therefore, it is expected to act as fluorescent probe for some 
biochemical systems like proteins (Tian et al.,  2003). 
 
The fluorescence quenching spectra of HSA at various percentage of progesterone or 
cholesterol are shown in Fig.(4.5) and Fig.(4.6), respectively. Obviously from the results, 
the fluorescence intensity of HSA gradually decreased while the peak position shows little 
or no change upon increasing the percentage of progesterone or cholesterol, indicating that 
both progesterone and cholesterol bind to HSA.  Under the same condition, no 
fluorescence of progesterone or cholesterol was observed. Which indicates that both 
progesterone and cholesterol could quench the auto fluorescence of HSA, and that the 
interaction between both progesterone and  cholesterol from one hand, and HSA from the 
other indeed exists, leading to a change in the  microenvironment around the tryptophan 
residue and further exposure of tryptophan residue to the polar solvent (Petitpas et al., 
2001; Wang. et al., 2007; Gerbanowski et al., 1999; Cui et al., 2008).  
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Figure 4.5: Fluorescence emission spectra of HSA in the absence and presence of 
progesterone in these ratios ( Prog:HSA a=0:10, b=2:10, c=6:10, d=10:10, e=14:10, 
f=18:10, g= free progesterone). 
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Figure 4.6: Fluorescence emission spectra of HSA in the absence and presence of 
cholesterol in these ratios ( chol:HSA a=0:10, b=2:10, c=6:10, d=10:10, e=14:10, f=18:10, 
g=free cholesterol) 
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4.2.1 Stern-Volmer quenching constants (Ksv) and the quenching rate 
         constant of the biomolecule (Kq). 
 
Fluorescence quenching refers to any process, which decreases the fluorescence intensity 
of a sample (Lakowicz, 2006), a variety of molecular interactions can result in quenching, 
these include excited-state reactions, molecular rearrangements, energy transfer, ground-
state complex formation, and collisional quenching (Peng et al., 2008). Fluorescence 
quenching can be induced by different mechanisms, usually classified into dynamic and 
static quenching (Cui et al., 2007).  
 
As discussed in chapter two assuming dynamic quenching is dominating, then the decrease 
in intensity is described by the well-known Stern-Volmer equation: 
 
                                                                                                                                 (4)   
In this expression F and F0 are the fluorescence intensities with and without quencher, Ksv 
is the Stern-Volmer quenching constant, Kq is the bimolecular quenching constant, τ0 is 
average lifetime of the biomolecule without quencher, and (L) is the quencher 
concentration. The Stern-Volmer quenching constant Ksv indicates the sensitivity of the 
fluorophore to a quencher. 
Linear  curves were plotted according to the Stern– Volmer equation as shown in Fig.(4.7) 
for progesterone- HSA complexes and Fig.(4.8) for cholesterol- HSA complexes. The 
Stern–Volmer quenching constant Ksv was obtained by the slope of the curves obtained in 
Fig. (4.7) and Fig.(4.8), and its value equals (6.26×102 L mol-1) for progesterone- HSA  
complexes and  (6.21×102 L mol-1) for cholesterol- HSA complexes. Obviously from 
equation 4 the value of Ksv=Kq τ0 , from which we can calculate the value of Kq using the 
fluorescence life time of 10-8 s for HSA (Cheng et al., 2006;  Lakowica et al.,  1973), to 
obtain Kq values of (6.20×1010 L mol-1s-1)for progesterone- HSA  complexes and 
(6.21×1010 L mol-1s-1) for cholesterol- HSA complexes. Which is larger than the maximum 
dynamic quenching constant for various quenchers with biopolymer (2 ×1010 L mol-1 s-1) 
(Lakowica et al.,  1973; Eftink, 1991).Which implies that the quenching is not initiated by 
dynamic collision but from formation of a complex, so static quenching is dominant (Cui 
et al., 2007; Wang et al., 2008). 
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Figure 4.7: The Stern-Volmer plot for progesterone- HSA complexes. 
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Figure 4.8: The Stern-Volmer plot for cholesterol- HSA complexes. 
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4.2.2 Determination of the binding constant using fluorescence spectrophotometer. 
 
When static quenching is dominant the modified Stern-Volmer equation could be used 
(Yang, et al., 1994):  
 
                                                                                                                                 (5) 
 
Where K is the binding constant of progesterone or cholesterol with HSA, and can be 
calculated by plotting 1/(F0-F) vs 1/L, see Fig.(4.9) and Fig.(4.10). The value of K equals 
the ratio of the intercept to the slope. The obtained values of K equals (6.56×102 M-1)for 
progesterone- HSA complexes from Fig.(4.9), and (0.214 × 104 M-1)for cholesterol- HSA 
complexes from Fig.(4.10), which agrees well with the value obtained earlier by UV 
spectroscopy and supports the effective role of static quenching. The highly effective 
quenching constant in this case has lead to a lower value of binding constant between the 
hormone or its parent compound and HSA, due to an effective hydrogen bonding between 
progesterone or cholesterol and HSA (Darwish et al., 2010).  
 
The acting forces between a small molecule substance and macromolecule mainly include 
hydrogen bond, van der Waals force, electrostatic force and hydrophobic interaction force. 
It was more likely that hydrophobic and electrostatic interactions were involved in the 
binding process. However, progesterone or cholesterol might be largely unionized under 
the experimental conditions, as expected from its structure. Hence, electrostatic interaction 
could be precluded from the binding process. Thus, the binding of progesterone or 
cholesterol to HSA includes the hydrophobic interaction (Cui et al., 2008). 
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Figure 4.9: The plot of 1/(Fo-F) vs (1/L)×104 for progesterone- HSA complexes. 
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Figure 4.10: The plot of 1/(Fo-F) vs (1/L)×104 for cholesterol- HSA complexes. 
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4.3 FT-IR Spectroscopy. 
 
FT-IR spectroscopy is a powerful technique for the study of hydrogen bonding (Li et al., 
2006), and has been identified as one of the few techniques that is established in the 
determination of protein secondary structure at different physiological systems (Sirotkin, et 
al., 2001; Surewicz, et al., 1993; Arrondo, et al., 1993). The information on the secondary 
structure of proteins arises from the amide bands which is a result from the vibrations of 
the groups around the peptide bonds of proteins. When drugs bind to a globular protein like 
HSA, changes in hydrogen bonding which is involved in the peptide linkages would occur, 
resulting in changes in the vibrational frequency of the different amide modes (Ganim, et 
al., 2006; Haris et al., 1999).  
The modes most widely used in protein structural studies are amide I, amide II and amide 
III. amide I band ranging from 1700 to 1600 cm-1 and arises principally from the C=O 
stretching (Vandenbussche, et al., 1992), and has been widely accepted to be used 
(Workman, 1998). The amide II band is primarily N-H bending with a contribution from 
C-N stretching vibrations, amide II ranging from 1600 to 1480 cm-1.And amide III band 
ranging from 1330 to 1220 cm-1 which is due to the C-N stretching mode coupled to the in-
plane N - H bending mode. See Fig.(4.11) (Goormaghtigh, et al., 1990; Sirotkin, et al., 
2001). 
 
 
 
 
 
 
 
Figure 4.11: Sample spectrum showing the three relevant regions for determination of 
protein secondary structure. Amide I (1700-1600 cm-1), amide II( 1600-1480 cm-1) and 
amide III (1330-1220 cm-1) (Vonhoff et al., 2010).  
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The second derivative of HSA free is shown in Fig.(4.12A) and Fig.(4.13A), where  the 
spectra is dominated by absorbance bands of amide I and amide II at peak positions 
1656cm -1 and 1543cm-1, respectively. Fig.(4.12B), shows the spectrum of progesterone- 
HSA complexes with different percentages of progesterone, and Fig.(4.13B), shows the 
spectrum of cholesterol- HSA complexes with different percentages of cholesterol. It is 
obviously seen as progesterone or cholesterol ratios was increased the intensities of the 
amide I, amide II and amide III bands decreased further in the spectra of all progesterone- 
HSA and cholesterol- HSA complexes. The reduction in the intensity of the three amide 
bands is related to the progesterone- HSA and cholesterol- HSA interactions.     
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Figure 4.12: A: The spectra of HSA free (second derivative) And B: (a, b, c, d, e, f) 
Progesterone-HSA with ratios (0:10, 2:10, 6:10, 10:10, 14:10, 18:10), respectively. 
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Figure 4.13: A: The spectra of HSA free (second derivative) And B: (a, b, c, d, e, f) 
Cholesterol-HSA with ratios (0:10, 2:10, 6:10, 10:10, 14:10, 18:10), respectively. 
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In Table (4.1) and Table (4.2) the peak positions of HSA with different ratios of 
progesterone or cholesterol are listed, respectively. For progesterone-HSA interaction the 
amide bands of HSA infrared spectrum shifted as listed in Table (4.1), for amide I band the 
peak positions have shifted as follows: 1616  to 1615cm-1, 1634 to 1628cm-1, 1656 to 
1658cm-1, 1682 to 1681cm-1, and 1696 to 1692cm-1. Also a peak at 1623cm-1 has 
disappeared after the interaction of progesterone with HSA. In amide II the peak positions 
have shifted as follows: 1496 to 1498cm-1, 1517 to 1516cm-1, 1543 to 1548cm-1, 1572 
to1569cm-1, and 1592 to 1596cm-1. In addition a new peak at 1584cm-1 appeared after the 
interaction of progesterone with HSA. In amide III region the peak positions have also 
been shifted in the following order: 1225 to 1226cm-1, 1243 to 1241cm-1, 1268 to 1266cm-
1, and 1315 to 1311cm-1. In addition a new peak has appeared at high molecular ratios of 
progesterone at 1276cm-1, also a peak at 1293cm-1 has disappeared after the interaction of 
progesterone with HSA. 
For cholesterol-HSA interaction the amide bands of HSA infrared spectrum shifted as 
listed in Table (4.2), for amide I band the peak positions have shifted as follows: 1616  to 
1614cm-1, 1623 to 1628cm-1, 1656 to 1657cm-1, 1682 to 1681cm-1, and 1696 to 1692cm-1. 
Also a peak at 1634cm-1 has disappeared after the interaction of cholesterol with HSA. In 
amide II the peak positions have shifted as follows: 1496 to 1497cm-1, 1517 to 1515cm-1, 
1543 to 1549cm-1, 1572 to1569cm-1, and 1592 to 1596cm-1. In addition a new peak at 
1584cm-1 appeared after the interaction of cholesterol with HSA. In amide III region the 
peak positions have also been shifted in the following order: 1268to 1269cm-1, 1293 to 
1296cm-1, and 1315 to 1313cm-1. In addition a peak at 1225cm-1 has disappeared, and a 
peak at 1243cm-1 remains unchanged after the interaction of cholesterol with HSA. 
The shifts in peak positions and shape of HSA amides after progesterone or cholesterol 
complexation with HSA come from the changes in protein secondary structure. The minor 
changes in peak positions can be attributed to the effect of the newly imposed H-bonding 
between the hormone and its parent compound (cholesterol) molecules with the protein. It 
is suggested that, the shift to a higher frequency for the major peak in amide I region 
(1656–1658cm-1) for progesterone- HSA complexes and (1656-1657cm-1) for cholesterol- 
HSA complexes came as a result of stabilization by hydrogen bonding by having the C–N 
bond assuming partial double bond character due to a flow of electrons from the C=O to 
the C–N bond (Jackson, et al., 1991).  
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Table 4.1: Band assignment in the absorbance spectra of HSA with different progesterone 
molecular ratios for amide I, amide II, and amide III regions 
Bands HSA free Prog:HSA
2:10 
Prog:HSA 
6:10 
Prog:HSA
10:10 
Prog:HSA 
14:10 
Prog:HSA
18:10 
1616 1616 1615 1613 1612 1615 
1623      
1634 1632 1630 1627 1627 1628 
1656 1654 1653 1658 1659 1658 
1682 1682 1682 1680 1679 1681 
 
Amide I 
(1700-1600) 
 
1696 1692 1691 1691 1691 1692 
 
1496 1497 1497 1498 1498 1498 
1517 1516 1515 1515 1515 1516 
1543 1546 1548 1548 1549 1548 
1572 1572 1570 1569 1567 1569 
  1589 1586 1584 1584 
Amide II 
(1600-1480) 
1592 1594 1595 1595 1596 1596 
 
1225 1226 1226 1226 1226 1226 
1243 1243 1243 1242 1241 1241 
1268 1269 1269 1267 1266 1266 
    1276 1276 
1293      
Amide III 
(1330-1220) 
1315 1314 1313 1312 1311 1311 
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Table 4.2: Band assignment in the absorbance spectra of HSA with different cholesterol 
molecular ratios for amide I, amide II, and amide III regions 
Bands HSA free Chol:HSA
2:10 
Chol:HSA
6:10 
Chol:HSA
10:10 
Chol:HSA 
14:10 
Chol:HSA
18:10 
1616 1613 1611 1612 1616 1614 
1623 1626 1626 1627 1627 1628 
1634      
1656 1655 1657 1657 1658 1657 
1682 1682 1681 1681 1681 1681 
 
Amide I 
(1700-1600) 
 
1696 1693 1692 1693 1693 1692 
 
1496 1497 1497 1496 1497 1497 
1517 1515 1514 1514 1515 1515 
1543 1547 1548 1548 1549 1549 
1572 1571 1570 1570 1570 1569 
 1582 1582 1582 1589 1584 
 
Amide II 
(1600-1480) 
1592 1595 1595 1595 1595 1596 
 
1225      
1243 1243 1243 1243 1243 1243 
1268 1270 1269 1269 1268 1269 
1293 1298 1298 1297 1297 1296 
 
Amide III 
(1330-1220) 
 1315 1314 1313 1315 1314 1313 
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The difference spectra for [(HSA + progesterone or cholesterol) - (HSA)] were obtained in 
order to monitor the intensity variations of these vibrations; the results are shown in 
Figures 4.14, 4.15, 4.16, 4.17. The results for progesterone- HSA interactions are 
illustrated in Fig.(4.14) for FT-IR spectra (top two curves) and difference spectra of HSA 
and its complexes with different progesterone percentages in amide I and amide II regions, 
and Fig.(4.15) for FT-IR spectra (top two curves) and difference spectra of HSA and its 
complexes with different progesterone percentages in amide III region. In amide I region 
clearly there is a strong negative feature at 1656cm-1, and in amide II region one negative 
feature was also observed at 1544cm-1(Fig.(4.14)). For amide III region two negative 
feature was observed at 1248cm-1 and at 1310cm-1 with a little shift as progesterone ratios 
was increased, another two weak negative features was observed at 1270cm-1 and 1301cm-
1 also with a little shift as the ratios of progesterone was increased (Fig.(4.15)).  
 
For cholesterol-HSA interaction the results are illustrated in Fig.(4.16) for FT-IR spectra 
(top two curves) and difference spectra of HSA and its complexes with different 
cholesterol percentages in amide I and amide II regions, and Fig.(4.17) for FT-IR spectra 
(top two curves) and difference spectra of HSA and its complexes with different 
cholesterol percentages in amide III region. In amide I region clearly there is a strong 
negative feature at 1654cm-1 with a little shift in its position, and in amide II region one 
negative feature was also observed at 1543cm-1 also with a little shift in its position 
(Fig.(4.16)). For amide III region two negative feature was observed at 1245cm-1 and at 
1311cm-1 with a little shift in their positions as cholesterol ratios was increased, another 
weak negative feature was observed at 1287cm-1 at low cholesterol concentration and 
disappeared as the molecular ratio of cholesterol was increased (Fig.(4.17)). 
 
It is clearly shown that the strong negative features in the difference spectra became 
stronger as percentages of progesterone or cholesterol were increased with a little shift in 
their positions, which are attributed to the intensity decrease in the amide I, II and III bands 
in the spectra of the progesterone– HSA and cholesterol- HSA complexes, that is due to the 
interaction (H bonding) of the progesterone or cholesterol with protein C=O and C-N 
groups, and the reduction of the proteins α-helix structure upon progesterone or 
cholesterol–HSA interaction (Purcell, et al., 2000; Krimm, et al.,1986). 
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The band at 1523 cm-1 of the free HSA, related to the tyrosine amino acid side-chain 
vibration (Fabian et al., 1994; Yamamoto et al., 1991; Matsuura, et al., 1986; 
Goormaghtigh, et al., 1990), exhibited no spectral changes upon progesterone or 
cholesterol complexation, which is indicative of no perturbation of the tyrosine residue in 
the progesterone or cholesterol– HSA complexes. 
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Figure 4.14: FT-IR spectra (top two curves) and difference spectra of HSA and its 
complexes with different progesterone concentrations in the region 1800-1500 cm-1 
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Figure 4.15: FT-IR spectra (top two curves) and difference spectra of HSA and its 
complexes with different progesterone concentrations in the region of 1330- 1220 cm-1. 
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Figure 4.16: FT-IR spectra (top two curves) and difference spectra of HSA and its 
complexes with different cholesterol concentrations in the region 1800-1500 cm-1. 
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Figure 4.17: FT-IR spectra (top two curves) and difference spectra of HSA and its 
complexes with different cholesterol concentrations in the region of 1330- 1220 cm-1. 
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Determination of the secondary structure of HSA and its progesterone or cholesterol 
complexes was carried out on the basis of the procedure described by Byler and Susi 
(Byler, et al., 1986). In this work, a quantitative analysis of the protein secondary structure 
for the free HSA and progesterone or cholesterol– HSA complexes in dehydrated films is 
determined from the shape of Amide I, amide II and amide III bands. Infrared Fourier self-
deconvolution with second derivative resolution and curve fitting procedures, were applied 
to increase spectral resolution and therefore to estimate the number, position and area of 
each component bands. The procedure was in general carried out considering only 
components detected by second derivatives and the half widths at half height (HWHH) for 
the component peaks are kept around 5cm-1, the above procedure was reported in a recent 
publication (Darwish et al., 2010). 
The component bands of amide I, II, and III regions were assigned to a secondary structure 
according to the frequency of its maximum a raised after Fourier self deconvolution have 
been applied; for amide I band ranging from 1610 to 1700cm-1  assigned as follows: 1610–
1624 cm-1 are generally represented to β-sheet, 1625–1640 cm-1 to random coil, 1646–1671 
cm-1 to α-helix, 1672–1787 cm-1 to turn structure, and 1689-1700cm-1 to β-antiparallel. For 
amide II ranging from 1480 to 1600cm-1, the absorption band  assigned in the following 
order: 1488–1504 cm-1 to β-sheet, 1508–1523 cm-1 to random coil, 1528–1560 cm-1 to α-
helix, 1562–1585 cm-1 to turn structure, and 1585-1598cm-1 to β-antiparallel. And for 
amide III ranging from 1220 to 1330cm-1 have been assigned as follows: 1220–1256 cm-1 
to β-sheet, 1257–1285 cm-1 to random coil, 1287–1301 cm-1 to turn structure, and 1302–
1329 cm-1 to α-helix. Most investigations have concentrated on Amide I band assuming 
higher sensitivity to the change of protein secondary structure (Vass, et al., 1997). 
However, it has been reported that amide II and amide III bands has high information 
content and could be used for prediction of  proteins secondary structure (Oberg et al., 
2004; Jiang et al., 2004; Xie et al., 2003; Liu, et al., 2003). 
Based on the above assignments, the percentages of each secondary structure of HSA were 
calculated by integrated areas of the component bands in amide I, amide II and amide III  
then summed and divided by the total area. The obtained number is taken as the proportion 
of the polypeptide chain in that conformation. 
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The Secondary structure determination for the free HSA and its progesterone or cholesterol 
complexes, are given in (Table (4.3), and Table (4.4)). The second derivative resolution 
enhancement and curve – fitted Amide I, Amide II, and Amide III regions and secondary 
structure determinations of the free human serum albumin (A, B) and its progesterone or 
cholesterol  complexes (C, D) with the highest percentage of progesterone or cholesterol  
in dehydrated films are shown in (Fig. (4.18), Fig.(4.19), Fig.(4.20), Fig.(4.21), Fig.(4.22), 
and Fig.(4.23)). 
 
Table (4.3) and Table (4.4) shows the content of each secondary structure of HSA before 
and after the interaction with progesterone or cholesterol at different ratios, respectively. It 
is obviously seen that α-helix percentage decrease with the increase of progesterone or 
cholesterol ratios in the calculations, and this trend is consistent in the three Amide 
regions. 
 
For progesterone- HSA interaction: in amide I region HSA free consists of (17%) β-sheet, 
(8%) random coil, (57%) α-helical structure, and (18%) turn structure. After progesterone- 
HSA complexation, see Fig.(4.18) and Table (4.3), α-helical structure reduced from 57% to 
49%, β-sheet increased from 17% to 34%, turn structure reduced from 18% to 15%, and 
the random coil reduced from 8% to 2%. In amide II region HSA free consists of (25%) β-
Sheet, (7%) random coil, (53%) α-helical structure, and (15%) turn structure. After 
progesterone- HSA interaction, see Fig.(4.19) and Table (4.3), α-helical structure reduced 
from 53% to 43%, β-sheet increased from 25% to 33%, turn structure reduced from 15% to 
14%, and the random coil increased from 7% to 10%.  And in amide III region HSA free 
consists of (40%) β-Sheet, (8%) random coil, (46%) α-helical structure, and (6%) turn 
structure. After progesterone- HSA interaction, see Fig.(4.20) and Table (4.3), α-helical 
structure reduced from 46% to 41%, β-sheet increased from 40% to 45%, turn structure 
reduced from 6% to 4%, and the random coil increased from 8% to 10%. 
 
For cholesterol- HSA interaction: in amide I region HSA free consists of (17%) β-sheet, 
(8%) random coil, (57%) α-helical structure, and (18%) turn structure. After cholesterol- 
HSA complexation, see Fig.(4.21) and Table (4.4), α-helical structure reduced from 57% to 
53%, β-sheet increased from 17% to 29%, turn structure reduced from 18% to 17%, and 
the random coil reduced from 8% to 1%. In amide II region HSA free consists of (25%) β-
Sheet, (7%) random coil, (53%) α-helical structure, and (15%) turn structure. After 
  72
cholesterol- HSA interaction, see Fig.(4.22) and Table (4.3), α-helical structure reduced 
from 53% to 43%, β-sheet increased from 25% to 30%, turn structure increased from 15% 
to 16%, and the random coil increased from 7% to 11%.  And in amide III region HSA free 
consists of (40%) β-Sheet, (8%) random coil, (46%) α-helical structure, and (6%) turn 
structure. After cholesterol- HSA interaction, see Fig.(4.23) and Table (4.3), α-helical 
structure reduced from 46% to 38%, β-sheet increased from 40% to 46%, turn structure 
remained the same without changes, and the random coil increased from 8% to 10%. 
 
The reduction of α-helix intensity percentage in favor of the increase of β-sheets are 
believed to be due to the unfolding of the protein in the presence of progesterone or 
cholesterol as a result of the formation of H bonding between HSA and the hormone or 
hormone parent compound.  The newly formed H-bonding result in the C–N bond 
assuming partial double bond character due to a flow of electrons from the C=O to the C–N 
bond which decreases the intensity of the original vibrations (Jackson, et al., 1991). as 
discussed in chapter two the hydrogen bonds in α-helix are formed inside the helix and 
parallel to the helix axis, while for β-sheet  the hydrogen bonds take position in the planes 
of  β-sheets as the preferred orientations  especially in the anti-parallel sheets, so the 
restrictions on the formation of hydrogen bonds in β-sheet relative to the case in α-helix 
explains the larger effect on reducing the intensity  percentage of α-helix to that of β-sheet. 
Similar conformational transitions from an α-helix to β-sheet structure were observed for 
the protein unfolding upon protonation and heat denaturatio (Surewicz, et al., 1987; 
Holzbaur, et al., 1996). 
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Table 4.3: Secondary structure determination for Amide I, amide II, and amide III regions 
in HSA and its Progesterone complexes. 
HSA-Prog 
18:10(%) 
HSA-Prog 
14:10(%) 
HSA-Prog 
10:10(%) 
HSA-Prog        
6:10(%) 
HSA-Prog 
2:10(%) 
HSA 
free(%) 
2nd Structure 
Amide I 
34 30 30 31 31 17 β-sheets (cm-2) 
(1610-1624) 
(1689-1700) 
2 3 4 4 3 8 Random(cm-2) 
(1625-1640) 
49 53 52 49 51 57 α-hilex (cm-2) 
(1646-1669) 
15 16 14 15 15 18 Turn (cm-2) 
(1672-1687) 
Amide II 
33 33 32 33 30 25 β-sheets (cm-2) 
(1488-1504) 
(1585-1598) 
10 10 10 11 10 7 Random(cm-2) 
(1508-1523) 
43 43 45 43 46 53 α-hilex (cm-2) 
(1528-1560) 
14 14 13 13 14 15 Turn (cm-2) 
(1562-1585) 
Amide III 
45 44 46 41 41 40 β-sheets (cm-2) 
(1220-1256) 
10 11 7 13 9 8 Random(cm-2) 
(1257-1285) 
4 4 4 3 6 6  Turn (cm-2)     
(1287-1301) 
41 41 43 43 44 46 α-hilex (cm-2) 
(1302-1329) 
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Table 4.4: Secondary structure determination for Amide I, amide II, and amide III regions 
in HSA and its Cholesterol complexes. 
chol -HSA 
18:10(%) 
chol -HSA 
14:10(%) 
chol -HSA 
10:10(%) 
chol -HSA 
6:10(%) 
chol -HSA 
2:10(%) 
HSA 
free(%) 
2nd Structure 
Amide I 
29 26 25 23 23 17 β-sheets (cm-2) 
(1610-1624) 
(1687-1700) 
1 1 2 3 4 8 Random(cm-2) 
(1625-1640) 
53 55 56 57 57 57 α-hilex (cm-2) 
(1643-1671) 
17 18 17 17 16 18 Turn (cm-2)  
(1672-1687) 
Amide II 
30 32 29 28 29 25 β-sheets (cm-2)  
(1488-1504)  
(1585-1598) 
11 9 12 13 12 7 Random(cm-2) 
(1508-1523) 
43 41 42 42 42 53 α-hilex (cm-2) 
(1525-1560) 
16 18 17 17 17 15 Turn (cm-2) 
(1562-1585) 
Amide III 
46 45 46 47 45 40 β-sheets (cm-2) 
(1220-1256) 
10 11 8 7 8 8 Random(cm-2) 
(1257-1285) 
6 5 6 6 6 6    Turn (cm-2)    
(1287-1301) 
38 39 40 40 41 46 α-hilex (cm-2)  
(1302-1329) 
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Figure 4.18: Second-derivative enhancement and curve-fitted Amide I region (1610-1700 
cm-1) and secondary structure determination of the free human serum albumin ( A and B) 
and it progesterone complexes ( C and D) with 18:10 progesterone: HSA ratios. 
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Figure 4.19: Second-derivative resolution enhancement and curve fitted amide II region 
(1600-1480 cm-1) and secondary structure determination of the free human serum albumin  
(A,B) and its progesterone complexes (C,D) with 18:10 hormone: protein ratio. 
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Figure 4.20:   Second-derivative resolution enhancement and curve fitted amide III region 
(1330-1220 cm-1) and secondary structure determination of the free human serum albumin  
(A,B) and its progesterone complexes (C,D) with 18:10 hormone: protein ratio. 
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Figure 4.21: Second-derivative enhancement and curve-fitted Amide I region (1610-1700 
cm-1) and secondary structure determination of the free human serum albumin ( A and B) 
and it cholesterol complexes ( C and D) with 18:10 cholesterol: HSA ratios. 
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Figure 4.22: Second-derivative enhancement and curve-fitted Amide II region (1600-1480 
cm-1) and secondary structure determination of the free human serum albumin ( A and B) 
and it cholesterol complexes ( C and D) with 18:10 cholesterol: HSA ratios. 
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Figure 4.23:   Second-derivative resolution enhancement and curve fitted amide III region 
(1330-1220 cm-1) and secondary structure determination of the free human serum albumin  
(A,B) and its cholesterol complexes (C,D) with 18:10 cholesterol: protein ratio. 
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Progesterone or cholesterol interaction with HSA mainly induce changes in HSA 
secondary structure, reducing α-helical structure in favor of β-sheets, which indicates 
partial unfolding of HSA upon progesterone and cholesterol interaction. 
Cholesterol interaction with HSA is similar to the interaction of steroid hormones to HSA 
(Ha, et al., 2003), and the affinity of steroid hormones to HSA is low (L. K. Amundsen et 
al., 2007); which is obviously seen in our results with a low binding constants we got 
between progesterone or cholesterol interaction with HSA. Relatively cholesterol 
interaction with HSA was stronger than progesterone HSA interaction. This may be due to 
the chemical structure of progesterone and cholesterol; there are more side interaction in 
presence of cholesterol to interact with HSA. While in the presence of progesterone there 
is less side interaction, this is line with the reported results that cholesterol binds to HSA in 
subdomains IIA and IIIA (Ha et al., 2003), and progesterone have one binding site located 
in domain II (Kragh-Hansen, U.1981). 
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Chapter Five: 
Conclusions and future 
work 
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Chapter five 
Conclusions and future work 
 
The interaction between steroid hormones and albumin is of great interest from both the 
endocrinological and pharmaceutical point of view. In our work the interaction of 
progesterone and its parent compound cholesterol with HSA was investigated by means of 
UV-VIS spectrophotometer, Fluorescence spectrophotometer, and FT-IR spectroscopy. 
The experimental results indicates a low binding affinity between progesterone or 
cholesterol with HSA. From analysis of the UV spectrum, the binding constants for 
progesterone-HSA and cholesterol- HSA are (K=6.354×102 M-1, K= 0.2641×104 M-1), 
respectively. The analysis of the fluorescence spectrum yield binding constants  for 
progesterone-HSA and cholesterol-HSA interactions, that have been measured to be 
(K=6.56×102 M-1, K= 0.214 × 104 M-1), respectively. The binding constants obtained by 
different methods have very close values. Comparing the binding constants of progesterone 
and cholesterol, one can conclude, that progesterone interactions with albumins were 
substantially weaker than cholesterol-HSA interaction.  In addition, the values of Stern–
Volmer quenching constants and quenching rate constants for both progesterone and 
cholesterol were measured to be (Ksv=6.26×102 L mol-1, Kq=6.2×1010 L mol-1s-1) and 
(Ksv=6.21×102 L mol-1 , Kq=6.21×1010 L mol-1s-1), respectively. As a result, it was found 
that the decrease in fluorescence intensity can be considered as the result of static 
quenching, which is indicative of a complex formation between the protein with the 
hormone and cholesterol  molecules. 
 
Analysis of FT-IR spectrum indicated that increasing the concentration of progesterone or 
cholesterol lead to the unfolding of protein, decreasing the percentage of the α-helical 
structure in favor of β-sheet structure. Beside that it can be inferred that the binding forces 
which are involved in the binding process includes hydrophobic interactions. The newly 
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formed H-bonding result in the C–N bond assuming partial double bond character due to a 
flow of electrons from the C=O to the C–N bond which decreases the intensity of the 
original vibrations. 
 
These experimental results may be useful for drug design, and provides some important 
information for clinical study of steroid hormones. And since body temperature changes 
during inflammatory processes, therefore, this research need further studies such as 
thermodynamic parameters (enthalpy, free energy, entropy) at different temperature to 
investigate the changes in the binding characteristics of steroid hormones with HSA. 
 
Furthermore, it has been reported that progesterone caused appreciably more cholesterol 
accumulation than other steroid hormones such as testosterone (Butler et al., 1992). So a 
comparison study for cholesterol- HSA complexes with different concentrations of 
progesterone or testosterone on the binding constants, will be a useful guide for synthesis 
of efficient drugs, since existence of steroid hormones may influence the binding force of 
cholesterol with protein. 
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 الملخص
 
, ان توزيع و عمليات الأيض لكثير من العناصر البيولوجية في الجسم سواء كانت أمصال أو منتجات طبيعية
دراسة ارتباط مثل هذه الجزيئات , اذا . )ASH(مرتبطة بقدرة هذه العناصر على الارتباط مع بروتين الدم البشري 
ت واسعة النطاق على جوانب مختلفة لتفاعل بروتين الدم دراسا. مع بروتين الدم البشري حتمي وله اهمية أساسية
  .البشري مع أمصال لا تزال في التقدم لأهمية هذه الدراسات في العمليات العلاجية
مع ( البروجستيرون و المركب المؤلف له الكوليستيرول) في هذه الدراسة تم دراسة تأتير هرمونات الستيرويد
باستخدام جهاز مطياف ,  عند درجة الحموضة الفسيولوجية)nimublA mureS namuH(بروتين الدم البشري 
 ecnecseroulF( و جهاز انبعاث الاشعاع )retemotohportcepS SIV-VU(الاشعة فوق البنفسجية 
  .)RI-TF( و جهاز مطياف تحويل فوريير للأشعة تحت الحمراء )retemotohportcepS
البنفسجية لبروتين الدم تزداد بزيادة نسب البروجستيرون أو متصاص الأشعة فوق أظهرت النتائج أن شدة ا
 gnidniB(ومن طيف الاشعة فوق البنفسجية تم حساب ثابت الترابط . الكوليستيرول مع ثبات تركيز البروتين
  . للكوليستيرول)1-M 401 × 1462.0(  للبروجستيرون و )1-M 201 × 453.6( و القيم هي )tnatsnoC
استنتج أن البروجستيرون و الكوليستيرول له القدرة على خفض شدة الاشعاع , الاشعاع المنبعثومن خلال تحليل 
 تم )remloV-nretS(قيم ثابت . )gnihcneuq citatS(   المنبعث ذاتيا من بروتين الدم البشري من خلال الية
 )1-lomL 201× 12.6( لمركب البروجستيرون مع بروتين الدم و )1-lomL 201 × 62.6( حسابها حيث وجدت
  .لمركب الكوليستيرول مع بروتين الدم البشري
 لمركب البروجستيرون مع )1-M 201 × 56.6(ايضا من طيف الاشعاع المنبعث تم ايجاد ثابت الترابط و هو 
من الواضح أن هذه ,  لمزكب الكوليستيرول مع بروتين الدم البشري)1-M 401 × 412.0(بروتين الدم البشري و 
وان ثابت , يم تتناسب مع القيم التي تم الحصول عليها لثابت الترابط من جهاز مطياف الأشعة فوق البنفسجيةالق
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يتفق مع ما تم التوصل وبما ,  للكوليستيرول أكبر منه للبروجستيرون بما يتناسب مع تركيب كلا المركبينالترابط
  .اليه مسبقا
 و )noitulovnoced-fleS reiruoF(ت الحمراء مع تطبيق تقنية باستخدام جهاز مطياف تحويل فوريير للأشعة تح
 تم تحليل مناطق أميد واحد و أميد اثنان و )gnittif evruC( بالاضافة لتقنية )noituloser evitavired dnoceS(
ط  و الية ارتبا)erutcurtS yradnoceS(أميد ثلاثة في بروتين الدم البشري لتحديد بنية البروتين الثانوية 
لقد لوحظ انه مع زيادة تراكيز البروجستيرون أو الكوليستيرول الى بروتين الدم فان , بروتين الدمالهرمونات مع 
 تم تحديدها عند عدة نسب )skaeP(أيضا جميع مواقع القمم .  تقل )sdnaB noitprosbA(شدة حزم الامتصاص 
  .روتين الدم البشريمن البروجستيرون أو الكوليستيرول بالمقارنة مع ب
جهاز مطياف تحويل فوريير للأشعة تحت الحمراء أن البنية الثانوية  اضافة الى ذلك أظهر الطيف المقاس بواسطة
الذي ظهر في انخفاض في , تغيرت نتيجة اضافة نسب من البروجستيرون أو الكوليستيرول, لبروتين الدم البشري
هذا التباين و  , )steehs-β(المقارنة مع حزم الامتصاص الممثلة ل  ب)xileh-α(شدة حزم الامتصاص الممثلة ل 
و هو ما يفسر ,  في الجزيئات المعقدة)gnidnob-H(في الشدة يرجع الى تكوين الروابط الهيدروجينية الاختلاف 
   . لتكوين هذه الروابط)steehs-β( و )xileh-α(الميول الذاتي لكل من 
 
  
 
